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Abstract
The ehrlichiae are small Gram-negative obligate intracellular bacteria in the family Anaplasmataceae. Ehrlichial infection in
an accidental host may result in fatal diseases such as human monocytotropic ehrlichiosis, an emerging, tick-borne disease.
Although the role of adaptive immune responses in the protection against ehrlichiosis has been well studied, the
mechanism by which the innate immune system is activated is not fully understood. Using Ehrlichia muris as a model
organism, we show here that MyD88-dependent signaling pathways play a pivotal role in the host defense against ehrlichial
infection. Upon E. muris infection, MyD88-deficient mice had significantly impaired clearance of E. muris, as well as
decreased inflammation, characterized by reduced splenomegaly and recruitment of macrophages and neutrophils.
Furthermore, MyD88-deficient mice produced markedly lower levels of IL-12, which correlated well with an impaired Th1
immune response. In vitro, dendritic cells, but not macrophages, efficiently produced IL-12 upon E. muris infection through a
MyD88-dependent mechanism. Therefore, MyD88-dependent signaling is required for controlling ehrlichial infection by
playing an essential role in the immediate activation of the innate immune system and inflammatory cytokine production,
as well as in the activation of the adaptive immune system at a later stage by providing for optimal Th1 immune responses.
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Introduction
The mammalian innate immune system detects the presence of
microbial infection through germ line-encoded pattern recognition
receptors (PRRs). Toll-like receptors (TLRs), RIG-like receptors
(RLRs) and nucleotide-binding oligomerization domain-leucine
rich repeat containing (NLR) proteins serve as PRRs that
recognize different but overlapping microbial components,
frequently referred to as pathogen-associated molecular patterns
(PAMPs) [1]. TLRs detect microbial infection and activate
downstream signaling cascades such as the activation of MAP
kinases and NF-kB. TLR signaling and the resulting transcrip-
tional activation of immune response genes requires the adaptor
MyD88, except for TLR3 signaling, which requires another
adaptor, TRIF [1]. Phylogenetic analysis groups the TLRs into six
categories [2], and TLRs in each branch have similar ligands [2];
the TLR1 group, which includes TLR2/6/10, is specific for
lipoproteins, TLR4 for LPS, TLR3/7 and TLR8/9 for RNA and
DNA, TLR5 for flagellin, and TLR11 for protein(s) [2].
Interestingly, TLRs also localize to different cellular compartments
to facilitate ligand recognition [3]. TLRs can localize to the cell
surface (TLR1,2,5,6,10), endosomal surface (TLR3,7,8,9), or both
(TLR4,11,12,13) [3,4].
It has been shown that, in addition to TLRs, NLR proteins are
also important for the recognition and response against bacterial
infection [5,6]. For example, Nod1 and Nod2 recognize active
moieties in bacterial peptidoglycan and transcriptionally activate
immune response genes via a serine/threonine kinase, Rip2
[7,8,9,10]. Nod2 has been shown to respond to muramyl dipeptide
(MDP), consisting of MurNAc-L-Ala-D-isoGln (or D-Glu) [11,12].
This moiety is conserved in both Gram-positive and Gram-
negative organisms, suggesting that Nod2 may confer resistance to
a wide variety of bacteria. Nod1, on the other hand, has been
shown to detect GM (GlcNAc-MurNAc)-tripeptide containing
meso-DAP (diaminopimelic acid) as well as simpler peptide versions
containing meso-DAP [7,13]. Other NLR proteins, such as Nalp3
(Nlrp3), Nalp1 (Nlrp1) and Ipaf (Nlrc4) oligomerize upon
activation to form a protein complex called the inflammasome
together with the adaptor ASC (for Nalp3 and Nalp1 inflamma-
some) or without ASC (for Ipaf), which can activate caspase-1,
resulting in efficient IL-1b processing and secretion
[14,15,16,17,18,19].
Human monocytotropic ehrlichiosis (HME) is an emerging,
tick-borne disease caused by Ehrlichia chaffeensis, which is an NIAID
Category C priority pathogen [20,21]. E. chaffeensis infection in
human with delayed or ineffective treatment may be fatal,
particularly in immunocompromised hosts [22,23]. The ehrlichiae
are small, Gram-negative, and obligate intracellular bacteria in the
family Anaplasmataceae and reside in endosomal compartments,
primarily in macrophages or monocytes. Ehrlichiae frequently
cause persistent infection in their natural hosts, which appear to
utilize immune defense mechanisms against species-specific
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chaffeensis in deer, E. muris in mice, and E. ruminantium in sheep,
goats and cattle [20,24]. However, ehrlichiae infection in
accidental hosts may result in severe fatal disease, similar to toxic
shock-like disease, as seen in in E. chaffeensis infection in humans or
infection of the IOE (Ixodes ovatus) Ehrlichia strain in mice
[25,26,27].
E. muris, a natural pathogen in mice, is closely related to E.
chaffeensis and is frequently used as an Ehrlichia infection model in
mice [28]. Infection of E. muris in a laboratory strain of mice such
as BALB/c, AKR or C57BL/6 results in splenomegaly, anemia,
and splenic follicular hyperplasia followed by the development of a
low-level persistent infection [28,29]. Both CD4 and CD8 T cells
play important roles in the immune response against Ehrlichia,
including IFN-c production [30,31]. Outer membrane proteins
(OMPs) of the Ehrlichia membrane play important roles in both
pathogenesis and host defense, as they are the major targets of
protective antibodies and Ehrlichia-specific T cells [32,33]. NKT
cells are also activated during E. muris infection, primarily through
direct recognition of microbial lipids, which takes place in a
MyD88-independent manner [34].
Although E. muris epitopes for B and T cell activation have been
characterized, neither the E. muris ligand(s), nor the corresponding
host receptor(s), that activate the innate immune system are known
[32,33]. E. muris can induce inflammation in mice, but it appears that
E. muris lacks known TLR and NLR ligands, with the exception,
perhaps, of bacterial nucleic acids. Ehrlichiae lack the genes required
for the biosynthesis of LPS, peptidoglycan and flagellin, which can
elicit an innate immune response [35,36] In this study, we have found
that MyD88-dependent signaling is essential for protection against E.
muris infection. Upon E. muris infection, dendritic cells (DCs), but not
macrophages, produce large amounts of IL-12, which is important in
driving the Th1 immune responses that are crucial for controlling E.
muris infection.
Results
MyD88-dependent protection against E. muris
Although ehrlichiae infect and cause inflammation in humans,
mice, and many other mammals, its recognition mechanism remains
unknown. We used MyD88-deficient mice to investigate whether
TLRs play a role in the detection of and protection against E. muris.
We infected MyD88-deficient mice with E. muris by i.p. inoculation
and assessed bacterial load in blood and tissues by quantitative real-
timePCR (qPCR) using primers specificforthe E. muris dsb gene. In a
preliminary study, we found that the E. murisload didnotsignificantly
increase by day 6, but increased and peaked on day 10. Therefore, we
designated the first 10 days post infection as the acute phase, and the
following days up to day 14 as the convalescent phase of infection,
which corresponds with previous reports [29,37]. MyD88-deficient
mice demonstrated a higher E. muris bacterial load in the blood in
both phases (Figure 1A). In wild-type mice, E. muris was cleared
gradually from the spleen during the convalescent phase. In contrast,
MyD88-deficient mice had significantly increased bacterial loads at
both day 10 and 14 post infection (Figure 1A). We measured the
cytokine production in the serum of infected mice. Strikingly, there
was a high level of IL-12 p40 and IL-12 p70 in the serum of wild-type
mice infected with E. muris, whereas MyD88-deficient mice produced
a significantly lower level of these cytokines (Figure 1B). We did not
observe statistically significant differences in TNF-a and IL-6 levels in
the serum of wild-type and MyD88-deficient mice (Figure 1B).
E. muris infection in wild-type mice caused severe splenomegaly
that progressively became apparent after infection (Figure 2A and
B). MyD88-deficient mice, however, showed a milder degree of
splenomegaly (Figure 2A and B). Macroscopically, lymphoid
follicles in wild-type mice were smaller and markedly irregular in
shape compared to MyD88-deficient mice after infection. In
contrast, lymphoid follicles in MyD88-deficient mice were larger,
more uniform and distinct in shape. Additionally, the red pulp of
the spleen significantly expanded in wild-type mice but only to a
mild degree in MyD88-deficient mice (Figure 2C). Microscopical-
ly, this expansion was accompanied by an increased infiltration of
neutrophils and macrophages into the marginal zone and the red
pulp of the spleen with numerous apoptotic cells (Figure S1).
Larger numbers of apoptotic cells and lymphoblasts were observed
in the lymphoid follicles in wild-type mice than in MyD88-
deficient mice (Figure S1). These overall histopathological findings
in wild-type mice subjected to E. muris infection were consistent
with a previous report [29]. In order to quantify the increased
number of neutrophils and macrophages, we analyzed Gr-1
+
neutrophils and F4/80
+ macrophages by flow cytometry. The
number of neutrophils and macrophages increased significantly in
wild-type mice 10 days after E. muris infection, whereas the
number of those cells increased only mildly in MyD88-deficient
mice (Figure 2D). In summary, these results indicate that MyD88-
dependent signaling plays an important role in the protection
against E. muris infection by inducing inflammatory responses
accompanied by IL-12 production.
Reduced Th1 response in MyD88-deficient mice during
E. muris infection
Since IL-12 is an important cytokine in the development of
effector Th1 cells from helper CD4 T cells, reduced production
of IL-12 in the serum of MyD88-deficient mice suggests that they
may have an insufficient Th1 response [38]. Earlier reports have
shown that a Th1 immune response is required for efficient
ehrlichia clearance in mice [31,39]. Therefore, we isolated
splenocytes before and 10 days after infection of mice with E.
muris, and IFN-c production in gated splenic CD4 T cells was
analyzed by flow cytometry. There was no significant change in
the ratio of CD4 to CD8 splenic T cells during E. muris infection
between wild-type and MyD88-deficient mice (Figure S2).
However, while the percentage of IFN-c producing CD4 T
cells increased 10 days after infection in wild-type mice, the
increase of IFN-c producing cells was considerably less in
MyD88-deficient mice (Figure 3A). In order to assess Th1
differentiation ex vivo, we purified CD4 T cells from spleens 10
days after infection and restimulated them with plate-bound
antibodies against CD3 or a combination of CD3 and CD28 at
different concentrations. As shown in Figure 3B, the production
of IFN-c was prominent in CD4 T cells from wild-type mice
while CD4 T cells from MyD88-deficient mice produced
significantly less IFN-c. This cannot be attributed to insufficient
IL-2 production in MyD88-deficient T cells, as wild-type and
MyD88-deficient CD4 T cells produced similar levels of IL-2
after TCR ligation (Figure 3B), suggesting that MyD88-deficient
T cells retain the intrinsic ability to produce cytokines. Indeed,
MyD88-deficient CD4 T cells produced more IL-4 than wild-
type CD4 T cells upon TCR ligation (Figure 3B). Taken
together, these data suggest that MyD88 is required for Th1
responses during E. muris infection.
DCs but not macrophages produce IL-12 efficiently upon
E. muris infection
In order to find the major source of IL-12 production during E.
muris infection, we generated bone marrow-derived DCs and
macrophages from C57BL/6 mice and challenged them with E.
MyD88 in Ehrlichiosis
PLoS ONE | www.plosone.org 2 July 2010 | Volume 5 | Issue 7 | e11758Figure 1. MyD88-deficient mice were susceptible to E. muris infection and demonstrated impaired IL-12 production in vivo. Age and
sex-matched wild-type (n=10 at day 10, n=7 at day 14) and MyD88-deficient mice (n=6 at day 10, n=7 at day 14) were infected with E. muris i.p. for
10 and 14 days. (A) E. muris loads in blood and spleen were quantified by qPCR using primers specific for the E. muris dsb gene. Data were normalized
by qPCR data for the GAPDH gene in host genomic DNA. (B) Serum IL-12 p40, IL-12 p70, IL-6, and TNF-a levels from infected mice were assessed by
ELISA. A single circle represents an individual animal, and lines indicate the mean values. The P-values were determined by Student’s t-test (Wild type
vs. MyD88-/-). Data are representative of three independent experiments in A and B.
doi:10.1371/journal.pone.0011758.g001
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containing vacuoles (morulaes) in both DCs and macrophages as
observed by Diff-Quick and Hoechst33342 staining (Figure S3A).
Furthermore, E. muris proliferated efficiently in both DCs and
macrophages, as quantified by qPCR (Figure S3B). Interestingly,
while DCs could produce IL-12 p40 efficiently upon E. muris
infection, macrophages could produce only a small amount of IL-
12 p40 (Figure S3C). Both cell types produced only small amounts
of TNF-a and IL-6 upon E. muris infection (Figure S3C).
Collectively, these data suggest that DCs, but not macrophages,
can serve as a major source of IL-12 production during E. muris
infection.
The Nod-Rip2 pathway does not play a major role in the
recognition of E. muris in DCs
Since ehrlichiae are obligate intracellular bacteria, we tested
whether members of the cytoplasmic NLR protein family have the
ability to detect E. muris. Caspase recruitment domain (CARD)
containing NLR proteins (NLRC proteins) such as Nod1 and Nod2
requirethekinase Rip2 for downstreamsignaling, which involves NF-
kB activation and the induction of proinflammatory cytokines
[10,40]. Therefore, in order to reveal the role of Nod1 and Nod2
in the detection of E. muris, we generated bone marrow-derived DCs
from Rip2-deficient mice. Cells were infected with E. muris,a n d
cytokine production and bacterial loads were assessed. Levels of
Figure 2. MyD88-deficient mice exhibited milder splenomegaly and leukocyte infiltration upon E. muris infection. Wild-type (n=10at
day 10, n=7 at day 14) and MyD88-deficient mice (n=6 at day 10, n=7 at day 14) were infected with E. muris i.p. for 10 and 14 days. (A and B)
MyD88-deficient mice demonstrated reduced splenomegaly. Spleens were removed from the mice 10 days after E. muris infection and photographed
in A. (B) Spleen weight was measured and normalized to body weight. A single circle represents an individual animal, and lines indicate the mean
values. P-values were determined by Student’s t-test (Wild type vs. MyD88-/-). (C) Spleens from infected mice were H&E-stained and photographed.
Scale bar, 1 mm. (D) Reduced recruitment of neutrophils and macrophages in E. muris-infected MyD88-deficient mice. Surface expression of Gr-1 or
F4/80 from total splenocytes was analyzed by flow cytometry. Numbers beside outlined areas indicate the percentage of Gr-1
+ or F4/80
+ cells among
total splenocytes. N, neutrophils; M, macrophages. Data are representative of at least three independent experiments in A–D.
doi:10.1371/journal.pone.0011758.g002
MyD88 in Ehrlichiosis
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wild-typeDCs were comparable tothat inRip2-deficient DCs (Figure
S4A). E. muris infection induced similar numbers of bacteria-
containing vacuoles in wild-type and Rip2-deficient DCs (Figure
S4B). There was also no significant difference in E. muris bacterial
load between wild-type and Rip2-deficient DCs (Figure S4C).
Collectively, these data indicate no or little involvement of Rip2 in
E. muris detection, suggesting that the NLR family proteins Nod1 and
Nod2 do not play major roles in the recognition of E. muris in DCs.
NLR proteins such as Nalp3 (Nlrp3) or Ipaf (Nlrc4) activate
caspase-1, resulting in cleavage and maturation of IL-1b
[14,15,16,17,18]. Therefore, we sought to determine whether E.
muris infection can induce IL-1b secretion in bone marrow-derived
macrophages from wild-type, Ipaf-deficient, Nalp3-deficient and
Asc-deficient mice. These cells were infected with E. muris in vitro
and IL-1b production was assessed by ELISA. We could not detect
IL-1b production in macrophages from any strain of mice,
suggesting that caspase-1 activating NLR proteins may not play a
major role in the recognition of E. muris (Figure S5).
MyD88 is required for efficient production of IL-12 from
DCs upon E. muris infection
Since DCs but not macrophages produce IL-12 p40 efficiently,
we analyzed IL-12 p40 production in MyD88-deficient dendritic
cells. Both wild-type and MyD88-deficient DCs were infected with
E. muris and cytokine production was assessed by ELISA. As
shown in Figure 4A, wild-type DCs produced a significantly
greater amount of IL-12 p40 than MyD88-deficient DCs upon E.
muris infection. Both TNF-a and IL-6 production decreased in
MyD88-deficient DCs as compared to wild-type cells, although
even wild-type DCs produced relatively low levels of these
proinflammatory cytokines (Figure 4A). The decreased production
of IL-12 p40 in MyD88-deficient DCs was not attributable to the
difference in number of bacteria in the cells since the formation of
bacterial vacuoles and the bacterial load in wild-type and MyD88-
deficient DCs were comparable (Figure 4B and C).
Although less able than DCs, macrophages can produce
measurable amounts of IL-12 p40 during E. muris infection (Figure
S3C). Therefore, we challenged wild-type and MyD88-deficient
Figure 3. MyD88-deficient mice had reduced Th1 immune responses during E. muris infection. (A) The number of IFN-c producing CD4
+ T
cells decreased in infected MyD88-deficient mice. Mice were infected with E. muris for 10 days. Total splenocytes were gated for CD4 surface
expression, and the expression of intracellular IFN-c and IL-4 was analyzed by flow cytometry (upper panel). Flow cytometric analysis of intracellular
IFN-c expression in splenic CD4
+ T cells from uninfected (open histograms) or infected (shaded histograms) mice (lower panel). Numbers in top left
quadrants indicate the percentage of IFN-c producing cells in the gated CD4
+ T cells. (B) Production of IFN-c, IL-4, and IL-2 from splenic CD4
+ T cells
was analyzed by ELISA after restimulation with plate-bound anti-CD3 and anti-CD28 antibodies at the indicated concentrations. Error bars represent
SD of triplicate samples. The P-values were determined by Student’s t-test (Wild type vs. MyD88-/-). *P,0.05. **P,0.01. Data are representative of at
least three independent experiments in A and B.
doi:10.1371/journal.pone.0011758.g003
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p40. The production of IL-12 p40 was dependent on MyD88 as
MyD88-deficient macrophages failed to produce IL-12 p40
(Figure S6A). Wild-type macrophages could also produce TNF-a
and IL-6 while MyD88-deficient macrophages produced these
cytokines at a significantly lower level (Figure S6A). Again, this
decrease was not due to failure of E. muris growth in MyD88-
deficient macrophages since we observed similar numbers of
bacteria-containing vacuoles and bacterial loads in wild-type and
MyD88-deficient macrophages (Figure S6B and C).
TLR-dependent recognition of E. muris
MyD88 is required for not only TLR, but also IL-1 and IL-18
receptor signaling [41]. Caspase-1 is required for the cleavage and
maturation of IL-1 and IL-18 into their biologically active forms
[42,43,44]. In order to define the role ofTLRsin the recognition of E.
muris, we used caspase-1-deficient cellsas acontrol against IL-1/IL-18
function. Caspase-1-deficient DCs infected with E. muris as well as
stimulated with TLR ligands produced levels of IL-12 p40
comparable to those of wild-type DCs (Figure 5A), indicating that
the IL-1/IL-18 family does not play a role in E. muris recognition. It
Figure 4. MyD88 is required for IL-12 production in E. muris-infected DCs. Bone marrow-derived DCs from wild-type and MyD88-deficient
mice were infected with E. muris for the indicated time period. (A) Cytokine production from infected cells was assessed by ELISA. LPS (10 ng/ml) and
poly(I:C) (50 mg/ml) stimulations were used as controls. (B) Infected cells (5 days post infection) were stained by Diff-Quick staining. Scale bar, 10 mm.
(C) Bacterial loads in infected cells were quantified by qPCR using primers specific for the E. muris dsb gene. Data were normalized by qPCR data for
the GAPDH gene in host genomic DNA. Error bars represent the SD of triplicate samples. The P-values were determined by Student’s t-test (MyD88+/
+ vs. MyD88-/-). *P,0.05. **P,0.01. Data are representative of at least three independent experiments in A–C. N.D., not detected.
doi:10.1371/journal.pone.0011758.g004
MyD88 in Ehrlichiosis
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require UNC93B1 for their endolysosomal translocation from the
endoplasmic reticulum [45,46]. Since E. muris grows in vacuoles in
thecytoplasm,wetestedwhetherE. muris recognition isdependenton
UNC93B1, using triple defective (3d) mice in which UNC93B1 is
mutated and non-functional, resulting in defective TLR3, 7 and 9
signaling [45]. We found that 3d DCs produced similar levels of IL-
12 p40 as compared to wild-type DCs, although 3d DCs did not
respond to ligands recognized by TLR9 (CpG DNA) or TLR7 (R-
848) (Figure 5B). Taken together, these data indicate that E. muris
recognition by DCs is in a caspase-1-independent and MyD88-
dependent manner, suggesting that UNC93B1-independent TLR(s)
may play a major role in E. muris recognition.
Known TLRs do not appear to play a role in the
recognition of E. muris in DCs
To identify which TLR is involved in the recognition of E. muris,
we generated DCs from Tlr2, 3, 4, 5, 7, 9 and 11-deficient mice.
Those cells were infected with E. muris and analyzed for IL-12 p40
production. Surprisingly, DCs deficient for any TLR showed a
normal response to E. muris infection (Figure S7A and B). It has
been shown that TLR1 and TLR6 cooperates with TLR2 for
ligand recognition[47]. Therefore, these data indicate that TLR1,
2, 3, 4, 5, 6, 7, 9 and 11 may not play a major role in the
recognition and host defense against E. muris infection.
Discussion
Although adaptive immune responses during ehrlichiosis have
been well characterized, the mechanism by which the bacteria
activate an innate immune response has remained unexplored.
Ehrlichiae are small obligate intracellular bacteria and have
naturally evolved to hide from the immune system in order to
survive in host cells. Intracellular bacteria grow in either in the
cytoplasm or in specialized organelles that do not fuse with
lysosomes, and must have strategies to escape from innate immune
surveillance. Such mechanisms include the deletion or conversion
of ligands into undetectable forms, rendering the organisms
‘‘invisible’’ from the innate immune system of host cells. For
example, Coxiella burnetii evades TLR4 by expressing a nonstimu-
latory lipid A and also lacks flagellin, a ligand for TLR5 and Ipaf
[48,49]. Similarly, ehrlichiae do not possess LPS, flagellin and
peptidoglycan, but are still able to induce inflammation, indicating
that the mammalian innate immune system can sense ehrlichiae.
In this study, we showed that MyD88 is required for host
protection against E. muris infection. MyD88-deficient mice
suffered from increased loads of E. muris in both blood and the
spleen, which was accompanied by a decreased inflammatory
response in the spleen, as well as reduced IL-12 production
(Figure 1 and 2). Splenomegaly and recruitment of macrophages/
neutrophils were less prominent in MyD88 deficient mice,
Figure 5. Recognition of E. muris in DCs is IL-1/IL-18 signaling and UNC93B1-independent. Bone marrow-derived DCs from wild-type,
caspase-1-deficient (A), or 3d (B) mice were infected with E. muris for the indicated time period, and IL-12 p40 production from infected cells was
assessed by ELISA. LPS (10 ng/ml), CpG (1 mM), R-848 (1 mM) and Pam3CSK4 (1 mg/ml) stimulations were used as controls. Error bars represent the SD
of triplicate samples. Data are representative of three independent experiments in A and B. N.D., not detected.
doi:10.1371/journal.pone.0011758.g005
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deficient mice correlate with less efficient bacterial clearance
(Figure 2). MyD88 is also important for the induction of a proper
Th1 response during E. muris infection, as shown in both in vivo and
ex vivo assays wherein CD4 T cells from MyD88-deficient mice
produced less IFN-c (Figure 3). Therefore, since it is likely that a
Th1 response, in addition to the recruitment of myeloid cells, is
important for host protection against ehrlichial infection, our data
suggests that MyD88-mediated recognition of ehrlichiae is
important for optimal induction of Th1 immune responses.
IL-12 is an important cytokine that can induce the differenti-
ation of Th1 effector cells from activated CD4 T cells [38]. Our
data suggest that during E. muris infection, DCs may be a major
source of IL-12. Bone marrow-derived DCs produce a large
amount of IL-12 p40 in a MyD88-dependent manner, although
bone marrow-derived macrophages produced only a small amount
of IL-12 p40 in in vitro ehrlichial infection (Figure 4 and Figure S3).
It has been reported recently that antigen presentation by DCs
plays an important role in the immune response against ehrlichial
infection [50]. Our findings indicate that in addition to ehrlichial
antigen presentation, DCs may also contribute to a strong host
defense against ehrlichia infection by driving strong Th1 immune
responses.
Our data suggest that TLR(s) play a role in the recognition of E.
muris since MyD88, but not caspase-1, is required for a response
against E. muris infection in DCs (Figure 4 and 5). Recently it was
reported that caspase-1 cleaves Mal/Tirap to produce its
functional form. TLR2 and TLR4 responses in DCs may not
require caspase-1 because a non-cleaved Mal/Tirap may still be
functional in DCs, as suggested previously [51]. The identity of the
TLR responsible for the recognition of ehrlichiae remains a
pressing and intriguing question. Excluding bacterial DNA/RNA,
ehrlichiae do not possess known TLR ligands. However, Tlr3,
Tlr7 and Tlr9-deficient dendritic cells respond normally to E. muris
infection. 3d DCs which cannot respond to ligands for TLR3, 7, 8,
and 9, also produced a normal response to E. muris infection,
suggesting that E. muris is not detected by any of these endosomal
TLRs (Figure 5B and Figure S7B). Our data also showed that DCs
from Tlr2, 4, 5 or 11-deficient mice responded to E. muris infection
with levels of IL-12 p40 production comparable to DCs from wild-
type mice (Figure S7). As for the remaining known TLRs, it has
been shown that TLR1 and TLR6 heterodimerize with TLR2 to
facilitate ligand recognition, and there is no murine homolog of
TLR10 [47]. These indicate that the eleven TLRs that have been
previously characterized may not be involved in E. muris
recognition. It is possible that multiple TLRs contribute partially,
and the sum of those effects is equivalent to the loss of functionality
observed in MyD88-deficient cells. An alternate possibility is that
an uncharacterized TLR accounts for the recognition of E. muris.
Unlike humans, mice and other lower vertebrates have the TLR11
subfamily, which includes TLR12 and TLR13, whose ligands and
functions are unidentified [2]. The TLR11 gene exists in humans
but is not functional due to the presence of a stop codon in the
leucine rich repeats [52]. It will be interesting to test if these
uncharacterized TLRs are responsible for E. muris recognition in
the future.
In addition to TLRs, there have been numerous reports of
detection of intracellular bacteria by NLR proteins. For example,
Listeria monocytogenesis infection activates Nalp3 and Nod2, Legionella
pneumophillae infection activates Nod2, Birc1e and Ipaf, and
Salmonella typhi infection activates Nalp3 and Ipaf
[9,17,18,53,54,55,56,57,58,59]. Interestingly, our data indicate
that E. muris seems to be unable to activate known NLRs. E. muris
infection in macrophages did not induce IL-1b secretion,
indicating that caspase-1 activating NLR proteins such as Nalp3
or Ipaf are not involved in E. muris recognition (Figure S5). Also, E.
muris infection in Rip2-deficient DCs resulted in IL-12 p40
production comparable with wild-type cells, indicating that Nod1
and Nod2 do not play major roles in E. muris recognition (Figure
S4). Indeed, E. muris possess neither peptidoglycan, which contain
the active moieties that are ligands for Nod1 and Nod2, nor
flagellin, a ligand for Ipaf.
In conclusion, this study has demonstrated the importance of
MyD88-mediated inflammatory and Th1 responses to the host
defense against ehrlichial infection. Furthermore, we have
identified DCs as a major source of IL-12 during E. muris
infection. Although the specific TLR that recognizes E. muris
remains unknown, our data suggests that obligate intracellular
bacteria can elicit strong innate immune responses via TLR
signaling. To our knowledge, this is the first report describing the
role of the MyD88 signaling pathway in the recognition of
intracellular bacteria belonging to the genus Ehrlichia.
Materials and Methods
Reagents
LPS from Salmonella minnesota was from Alexis. Phosphorothio-
ate-modified CpG oligo DNA was synthesized by Integrated DNA
Technology. Poly(I:C) was from Amersham Pharmacia Biotech.
Flagellin from S. typhimurium and Pam3CSK4 were from Invivo-
Gen. R-848 was from GLSynthesis Inc.
Mice
MyD88, Tlr2, Tlr3, Tlr4, Tlr5, Tlr7, Tlr9, Tlr11, Rip2,
caspase-1, ASC, Ipaf and Nalp3 deficient mice were established as
described and kindly provided by Drs. Shizuo Akira (Osaka
University), Richard Flavell, Yasunori Ogura (both at Yale
University), Sankar Ghosh (Colombia University), Vishva Dixit,
Sanjeev Mariathasan (both at Genentech), Douglas Golenbock
(University of Massachusetts), Ann Marshak-Rothstein (Boston
University) [10,15,17,42,52,60,61,62,63,64,65,66]. 3d mice were
established as previously (MMRRC: 010466-UCD) [45]. C57BL/
6 mice were from Taconic Farm, Inc. Mice were maintained
under specific pathogen-free conditions and in vivo infection studies
were performed in microisolator cages within the ABSL-2 animal
rooms in the Dana-Farber Cancer Institute Animal Research
Facility. All mice were maintained and used in accordance with
institutional and National Institutes of Health guidelines. All
animal work was approved by the IACUC committee (#04-044
and 04-045). Harvard Medical School and Dana-Farber Cancer
Institute are accredited by the American Association for the
Accreditation of Laboratory Animal Care.
Bacterial stocks and in vitro Ehrlichia infection of cells
E. muris, monocytotropic ehrlichial strain (ATCC VR-1411) was
used in this study. E. muris was cultivated in DH82 cells with 5%
FBS-supplemented DMEM at 37uC. Ehrlichiae were harvested
when 90–100% of the cells were infected, and stored 280uCi n
sucrose-phosphate-glutamate buffer (0.218 M sucrose, 3.8 mM
KH2PO4, 7.2 mM K2HPO4, and 4.9 mM monosodium glutamic
acid, pH 7.0), and used for in vitro infection. The cells were
cultured without antibiotics and E. muris bacterial stock was added
to the cells. Infected cells were stained by Diff-Quick (Imeb Inc) or
Hoechst 33342 (Invitrogen) staining. In order to produce virulent
infectious stocks for in vivo infections, live mice were used as
described previously [29,39]. Briefly, C57BL/6 mice were
inoculated i.p. with 0.5 ml of a 10
21 dilution of the frozen stock.
On day 9 after inoculation, the mice were sacrificed, the spleens
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phosphate-glutamate buffer. Large particles of debris were
removed by centrifugation at 500 g for 5 min, and the supernatant
was then aliquoted and stored at 280uCa sa1 0
21 stock of E.
muris.
Bone marrow-derived macrophages
Bone marrow-derived macrophages were prepared as described
[9]. Briefly, bone marrow from tibia and femur was obtained by
flushing with DMEM (Invitrogen). The medium was DMEM
supplemented with 10% heat-inactivated FBS, glutamine (both
from Invitrogen) and 30% L929 cell supernatant containing M-
CSF. Bone marrow cells were cultured in 10 ml at an initial
density of 1610
6 cells/ml in 100 mm petri dish (Becton
Dickinson) at 37uC in humidified 10% CO2 for 6 days. Cells
were harvested with cold PBS (Invitrogen), washed, resuspended in
DMEM supplemented with 10% FBS and used at a density of
2610
5 cells/ml for experiments unless mentioned otherwise.
Bone marrow-derived DCs
DCs were grown from wild-type and various knockout mice as
described previously [67]. Briefly, bone marrow from tibia and
femur was obtained as described above, and bone marrow cells
were cultured in RPMI 1640 medium containing 10% heat-
inactivated FBS, 50 mM of 2-ME, and 2 mM of glutamine
supplemented with 3% J558L hybridoma cell culture supernatant
containing GM-CSF. The culture medium containing GM-CSF
was replaced every other day. At day 6 of culture, nonadherent
cells and loosely adherent DC aggregates were harvested, washed,
resuspended in RPMI 1640 supplemented with 5% FBS and used
at a density of 2610
5 cells/ml for experiments unless mentioned
otherwise.
Ehrlichia challenge of mice in vivo
In vivo E. muris infection method was established previously using
E. muris stock prepared from the spleen of the infected mice
[29,39]. Briefly, age (6–8 weeks old) and sex matched groups of
mice were infected i.p. with E. muris with 250 mlo fa1 0
21 dilution
of the E. muris stock. On the indicated days of infection, mice were
sacrificed, and immune responses were assessed. Selected organs
were harvested for histology, and bacterial loads were determined
by qPCR. Samples of spleen were fixed with 10% formalin and
stained by hematoxylin and eosin (H&E) for histopathological
examination.
CD4 T cells
CD4 T cells were isolated from spleen using a L3T4 CD4
microbeads (Mitenyi Biotec.) and stimulated with anti-CD3 and/
or anti-CD28 (eBioscience) antibody for 24 hours. Culture
supernatant was harvested for the measurement of IFN-c, IL-4,
and IL-2.
Determination of Ehrlichia bacterial load in tissues and
cells
Since E. muris is an obligatory intracellular bacterium that does not
grow outside of the cells, quantification method for the Ehrlichia load
was established previously using qPCR [29,39]. Briefly, the ehrlichial
load was determined by qPCR (with SYBR Green) of the Ehrlichia dsb
gene (GenBank accession number:AY236484), which encodes a thio-
disulfide oxidoreductase or disulphide bond formation protein of E.
muris.P r i m e rs e q u e n c e sa r ea sf o l l o w :E. muris forward,
TTCTTTGACTATTCCTGTGGCTAC; E. muris reverse, AAT-
GACGCCTCACCGAGTAT; mouse GAPDH forward, CAAC-
TACATGGTCTACATGTTC; and GAPDH reverse, CTCGC-
TCCTGGAAGATG. The substrate for amplification was DNA
purified from samples using the DNeasy Tissue kit (Qiagen, Valencia,
CA). qPCR was performed using the 7300 real time PCR system
from Applied Biosystems. Results were normalized to GAPDH levels
in the same sample and expressed as relative Ehrlichia dsb amounts per
GAPDH amount.
Cytokine measurement
Concentrations of murine TNF-a (R&D Systems), IL-12 p40
(BD PharMingen), IL-6 (BD PharMingen), IFN-c (eBioscience),
IL-4 (eBioscience), and IL-2 (eBioscience) in the culture superna-
tants or in the mouse serum were determined by ELISA according
to the manufacture’s instructions.
Flow cytometric analysis
All antibodies used in this study were: NK1.1, IFN-c, IL-4,
CD4, CD8, CD80, CD86, CD11b, CD11c, CD69, CD3, B220,
F4/80, Gr-1. Intracellular staining was performed after staining
for surface markers. Cells were then fixed and permeabilized using
permeabilization/fixation buffer (eBioscience) for 30 min at 4uC,
and then stained with IFN-c or IL-4 antibodies diluted in
permeabilization buffer (eBioscience). For analysis of cell surface
molecule expression, stimulated cells were washed with ice cold
PBS, fixed, and stained with FITC-, PE- and APC-labeled
antibodies in the presence of anti-CD16 antibody for 30 min on
ice. Stained cells were washed, resuspended in PBS/1% FBS/
0.05% NaN3, and analyzed by FACSCalibur followed by analysis
using CELLQuest software (Becton Dickinson). All antibodies
were obtained from eBioscience.
Statistical analysis
All experiments were performed at least three times. All data are
expressed as Mean 6 SD. Data were subjected to Student’s t test
for analysis of statistical significance, and a P value of ,0.05 was
considered to be significant.
Supporting Information
Figure S1 Histopathology of infected MyD88-deficient mice.
Wild-type and MyD88-deficient mice were infected with E. muris
by i.p. for 10 days. Infected spleens were H&E-stained and
photographed. Scale bar, 0.1 mm. Data are representative of at
least three independent experiments.
Found at: doi:10.1371/journal.pone.0011758.s001 (8.27 MB TIF)
Figure S2 Similar CD4/CD8 T cell ratio between wild-type and
MyD88-deficient mice during E. muris infection. Wild-type and
MyD88-deficient mice were infected with E. muris for 10 days.
Total splenocytes were analyzed by flow cytometry for surface
expression of CD4 and CD8. Numbers in quadrants indicate the
percentages of CD8+ and CD4+ cells among total splenocytes.
Data are representative of at least three independent experiments.
Found at: doi:10.1371/journal.pone.0011758.s002 (0.45 MB TIF)
Figure S3 DCs but not macrophages produce IL-12 p40
efficiently during E. muris infection. Bone marrow-derived DCs
and macrophages were infected with E. muris for the indicated
time period. (A) Infected cells (5 days postinfection) were stained
by Diff-Quick and Hoechst 33342 staining. Scale bar, 10 mm. (B)
Bacterial loads in infected cells were quantified by qPCR using
primers specific for the E. muris dsb gene. Data were normalized
by qPCR data for the GAPDH gene in host genomic DNA. (C)
Cytokine production from infected cells was assessed by ELISA.
Error bars represent SD of triplicate samples. LPS (10 ng/ml)
MyD88 in Ehrlichiosis
PLoS ONE | www.plosone.org 9 July 2010 | Volume 5 | Issue 7 | e11758stimulation was used as a control. Data are representative of three
independent experiments in A-C.
Found at: doi:10.1371/journal.pone.0011758.s003 (8.11 MB TIF)
Figure S4 Rip2-independent E. muris recognition in DCs. Bone
marrow-derived DCs from wild-type and Rip2-deficient mice were
infected with E. muris for the indicated time period. (A) Cytokine
production from infected cells was assessed by ELISA. LPS
(10 ng/ml) stimulation was used as a control. (B) Infected cells (5
days post infection) were stained by Diff-Quick staining. Scale bar,
10 mm. (C) Bacterial loads in infected cells were quantified by
qPCR using primers specific for the E. muris dsb gene. Data were
normalized by qPCR data for the GAPDH gene in host genomic
DNA. Error bars represent SD of triplicate samples. Data are
representative of three independent experiments in A-C.
Found at: doi:10.1371/journal.pone.0011758.s004 (8.29 MB TIF)
Figure S5 IL-1b production by Asc-, Nalp3-, or Ipaf-deficient
macrophages infected with E. muris. Bone marrow-derived
macrophages from both wild-type and Asc-, Nalp3- or Ipaf-
deficient mice were treated with LPS (10 ng/ml) for 16 hours and
then infected with E. muris in vitro for the indicated time period or
stimulated with 2.5 mM ATP for 3 hours. IL-1b secretion in the
culture supernatants was assessed by ELISA. Error bars represent
SD of triplicate samples. Data are representative of three
independent experiments.
Found at: doi:10.1371/journal.pone.0011758.s005 (0.18 MB TIF)
Figure S6 MyD88-dependent E. muris recognition in macro-
phages. Bone marrow-derived macrophages from wild-type and
MyD88-deficient mice were infected with E. muris in vitro for the
indicated time period. (A) Cytokine production from infected cells
was assessed by ELISA. LPS (10 ng/ml) stimulation was used as a
control. (B) Infected cells (5 days postinfection) were stained by
Diff-Quick staining. Scale bar, 10 mm. (C) Bacterial loads in
infected cells were quantified by qPCR using primers specific for
the E. muris dsb gene. Data were normalized by qPCR data for
the GAPDH gene in host genomic DNA. Error bars represent SD
of triplicate samples. The p-values were determined by Student’s t-
test (MyD88+/+ vs. MyD88-/-). *P,0.05. **P,0.01. Data are
representative of at least three independent experiments in A-C.
N.D., not detected.
Found at: doi:10.1371/journal.pone.0011758.s006 (9.43 MB TIF)
Figure S7 TLR2/3/4/5/7/9/11 do not play major roles in E.
muris recognition. Bone marrow-derived DCs from wild-type,
TLR2/4/5/11-deficient (A), or TLR3/7/9-deficient (B) mice
were infected with E. muris for the indicated time period, and IL-
12 p40 production from infected cells was assessed by ELISA. LPS
(10 ng/ml), CpG (1 mM), R-848 (1 mM) and Pam3CSK4 (1 mg/
ml) stimulations were used as controls. Error bars represent SD of
triplicate samples. Data are representative of three independent
experiments in A and B. N.D., not detected.
Found at: doi:10.1371/journal.pone.0011758.s007 (1.00 MB TIF)
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